USRE29835E
(en)
|
1971-06-01 |
1978-11-14 |
Icn Pharmaceuticals |
1,2,4-Triazole nucleosides
|
US3798209A
(en)
|
1971-06-01 |
1974-03-19 |
Icn Pharmaceuticals |
1,2,4-triazole nucleosides
|
JPS5238939A
(en)
|
1975-09-23 |
1977-03-25 |
Nippon Telegr & Teleph Corp <Ntt> |
Optical coupler
|
US4614719A
(en)
*
|
1982-04-30 |
1986-09-30 |
Yamasa Shoyu Kabushiki Kaisha |
Process for producing ribavirin
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
US5463092A
(en)
|
1989-11-22 |
1995-10-31 |
Vestar, Inc. |
Lipid derivatives of phosphonacids for liposomal incorporation and method of use
|
US5026687A
(en)
|
1990-01-03 |
1991-06-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
|
US5210015A
(en)
|
1990-08-06 |
1993-05-11 |
Hoffman-La Roche Inc. |
Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
|
WO1993000910A1
(en)
|
1991-07-12 |
1993-01-21 |
Vical, Inc. |
Antiviral liponucleosides: treatment of hepatitis b
|
US5538848A
(en)
|
1994-11-16 |
1996-07-23 |
Applied Biosystems Division, Perkin-Elmer Corp. |
Method for detecting nucleic acid amplification using self-quenching fluorescence probe
|
US6391859B1
(en)
|
1995-01-27 |
2002-05-21 |
Emory University |
[5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
|
US5703058A
(en)
|
1995-01-27 |
1997-12-30 |
Emory University |
Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
|
WO1996023506A1
(de)
|
1995-02-01 |
1996-08-08 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Verwendung von 5' substituierten nukleosiden zur hemmung von resistenzbildung bei der zytostatikabehandlung und arzneimittel, enthaltend diese nukleoside
|
GB9505025D0
(en)
|
1995-03-13 |
1995-05-03 |
Medical Res Council |
Chemical compounds
|
DE19514523A1
(de)
|
1995-04-12 |
1996-10-17 |
Schering Ag |
Neue Cytosin- und Cytidinderivate
|
US5858389A
(en)
|
1996-08-28 |
1999-01-12 |
Shaker H. Elsherbini |
Squalene is an antiviral compound for treating hepatitis C virus carriers
|
PT1132393E
(pt)
|
1996-10-16 |
2003-08-29 |
Ribapharm Inc |
L-ribavirina e usos da mesma
|
EP0961775B1
(en)
|
1996-10-16 |
2004-07-14 |
ICN Pharmaceuticals, Inc. |
Purine l-nucleosides, analogs and uses thereof
|
US6509320B1
(en)
|
1996-10-16 |
2003-01-21 |
Icn Pharmaceuticals, Inc. |
Purine L-nucleosides, analogs and uses thereof
|
EP0903148B1
(en)
|
1997-09-21 |
2001-10-10 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
|
US6201262B1
(en)
|
1997-10-07 |
2001-03-13 |
Cree, Inc. |
Group III nitride photonic devices on silicon carbide substrates with conductive buffer interlay structure
|
US6703374B1
(en)
|
1997-10-30 |
2004-03-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Nucleosides for imaging and treatment applications
|
EP1167972B1
(en)
|
1998-01-23 |
2017-03-08 |
Kiadis Pharma Intellectual Property B.V. |
Enzyme catalyzed therapeutic agents
|
US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
DE69933860T2
(de)
|
1998-02-25 |
2007-05-31 |
Emory University |
2'-fluoronukleoside
|
US6787305B1
(en)
|
1998-03-13 |
2004-09-07 |
Invitrogen Corporation |
Compositions and methods for enhanced synthesis of nucleic acid molecules
|
WO1999049873A1
(en)
|
1998-03-27 |
1999-10-07 |
Regents Of The University Of Minnesota |
Nucleosides with antiviral and anticancer activity
|
ATE216591T1
(de)
|
1998-05-15 |
2002-05-15 |
Schering Corp |
Kombinationstherapie enthaltend ribavirin und interferon alpha bei patienten mit chronischer hepatitis c infektion, die nicht antiviral vorbehandelt sind
|
BR9911076A
(pt)
|
1998-06-08 |
2001-02-20 |
Hoffmann La Roche |
Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
|
GB9816358D0
(en)
|
1998-07-27 |
1998-09-23 |
Angeletti P Ist Richerche Bio |
Enzyme inhibitors
|
MXPA01001507A
(es)
|
1998-08-10 |
2003-09-10 |
Novirio Pharmaceuticals Ltd |
°l-2'desoxi-nucleosidos para el tratamiento de hepatitis b.
|
GB9821058D0
(en)
|
1998-09-28 |
1998-11-18 |
Univ Cardiff |
Chemical compound
|
AU2157000A
(en)
|
1998-12-18 |
2000-07-12 |
Schering Corporation |
Ribavirin-pegylated interferon alfa induction hcv combination therapy
|
US6923966B2
(en)
|
1999-04-08 |
2005-08-02 |
Schering Corporation |
Melanoma therapy
|
ATE429438T1
(de)
|
1999-07-22 |
2009-05-15 |
Celmed Oncology Usa Inc |
Enzym katalisierte therapeutische aktivierung
|
US7388370B2
(en)
|
2005-07-29 |
2008-06-17 |
Automotive Systems Laboratory Systems, Inc. |
Magnetic crash sensor
|
WO2001032153A2
(en)
|
1999-11-04 |
2001-05-10 |
Shire Biochem Inc. |
Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
JP2003523978A
(ja)
|
2000-02-18 |
2003-08-12 |
シャイアー・バイオケム・インコーポレイテッド |
ヌクレオシドアナログを用いるflavivirus感染の処置もしくは予防するための方法
|
KR20100003313A
(ko)
|
2000-04-13 |
2010-01-07 |
파마셋 인코포레이티드 |
간염 바이러스 감염 치료를 위한 3'- 또는 2'-하이드록시메틸 치환된 뉴클레오시드 유도체
|
EP1282632A1
(en)
|
2000-04-20 |
2003-02-12 |
Schering Corporation |
Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
ES2227203T3
(es)
|
2000-05-26 |
2005-04-01 |
Idenix (Cayman) Limited |
Metodos para tratar la infeccion por el virus de la hepatitis delta con beta-1-2'-desoxinucleosidos.
|
US6787526B1
(en)
|
2000-05-26 |
2004-09-07 |
Idenix Pharmaceuticals, Inc. |
Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
|
CN1315862C
(zh)
|
2000-05-26 |
2007-05-16 |
艾登尼科斯(开曼)有限公司 |
处理黄病毒和瘟病毒的方法和组合物
|
MY141594A
(en)
|
2000-06-15 |
2010-05-14 |
Novirio Pharmaceuticals Ltd |
3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
CN1291994C
(zh)
|
2000-07-21 |
2006-12-27 |
吉里德科学公司 |
核苷酸膦酸酯类似物前药及其筛选和制备方法
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
AR039558A1
(es)
|
2000-08-21 |
2005-02-23 |
Inspire Pharmaceuticals Inc |
Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
|
US20030008841A1
(en)
|
2000-08-30 |
2003-01-09 |
Rene Devos |
Anti-HCV nucleoside derivatives
|
BR0114636A
(pt)
|
2000-10-18 |
2004-02-10 |
Schering Corp |
Terapia combinada para hcv de interferon-alfa peguilado/ribavirina
|
CA2426187C
(en)
|
2000-10-18 |
2011-08-16 |
Pharmasset Limited |
Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
|
AU2002232660A1
(en)
|
2000-12-15 |
2002-06-24 |
Pharmasset Ltd. |
Antiviral agents for treatment of flaviviridae infections
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
SK286630B6
(sk)
|
2001-01-22 |
2009-02-05 |
Merck & Co., Inc. |
Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
|
GB0112617D0
(en)
|
2001-05-23 |
2001-07-18 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
WO2003000713A1
(en)
|
2001-06-21 |
2003-01-03 |
Glaxo Group Limited |
Nucleoside compounds in hcv
|
WO2003006490A1
(en)
|
2001-07-11 |
2003-01-23 |
Vertex Pharmaceuticals Incorporated |
Bridged bicyclic serine protease inhibitors
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
WO2003024461A1
(en)
|
2001-09-20 |
2003-03-27 |
Schering Corporation |
Hcv combination therapy
|
JP2005504087A
(ja)
|
2001-09-28 |
2005-02-10 |
イデニクス(ケイマン)リミテツド |
4’が修飾されたヌクレオシドを使用するc型肝炎ウイルス治療のための方法および組成物
|
DE60221875T2
(de)
|
2001-11-02 |
2007-12-20 |
Glaxo Group Ltd., Greenford |
4-(6-gliedrige)-heteroaryl-acyl-pyrrolidinderivate als hcv-inhibitoren
|
BR0214944A
(pt)
|
2001-12-14 |
2005-06-07 |
Pharmasset Ltd |
Nucleosìdeos de n4-acilcitosina para o tratamento de infecções virais
|
WO2003051899A1
(en)
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Deazapurine nucleoside libraries and compounds
|
WO2003055896A2
(en)
|
2001-12-21 |
2003-07-10 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza l-nucleosides
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
US6642204B2
(en)
|
2002-02-01 |
2003-11-04 |
Boehringer Ingelheim International Gmbh |
Hepatitis C inhibitor tri-peptides
|
CA2474563C
(en)
|
2002-02-13 |
2010-11-09 |
Merck & Co., Inc. |
Methods of inhibiting orthopoxvirus replication with nucleoside compounds
|
JP2005524662A
(ja)
|
2002-02-28 |
2005-08-18 |
ビオタ インコーポレーティッド |
ヌクレオシド5’−一リン酸模倣物およびこれらのプロドラッグ
|
JP2005525358A
(ja)
|
2002-02-28 |
2005-08-25 |
ビオタ インコーポレーティッド |
ヌクレオチド模倣体およびそのプロドラッグ
|
WO2003100017A2
(en)
|
2002-05-24 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having modified nucleoside units
|
US7449488B2
(en)
|
2002-06-04 |
2008-11-11 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
CA2488842A1
(en)
|
2002-06-17 |
2003-12-24 |
Merck & Co., Inc. |
Carbocyclic nucleoside analogs as rna-antivirals
|
AU2003248708A1
(en)
|
2002-06-17 |
2003-12-31 |
Isis Pharmaceuticals, Inc. |
Oligomeric compounds that include carbocyclic nucleosides and their use in gene modulation
|
AU2003269890A1
(en)
|
2002-06-21 |
2004-01-06 |
Isis Pharmaceuticals, Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
EP1572945A2
(en)
|
2002-06-27 |
2005-09-14 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
PL374792A1
(en)
|
2002-06-28 |
2005-10-31 |
Idenix (Cayman) Limited |
2' and 3'-nucleoside prodrugs for treating flaviviridae infections
|
TW200500374A
(en)
|
2002-06-28 |
2005-01-01 |
Idenlx Cayman Ltd |
2' and 3' -nucleoside produrgs for treating flavivridae infections
|
CN1678326A
(zh)
|
2002-06-28 |
2005-10-05 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2'-c-甲基-3'-o-l-缬氨酸酯核糖呋喃基胞苷
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
WO2004002944A1
(en)
|
2002-07-01 |
2004-01-08 |
Pharmacia & Upjohn Company |
Inhibitors of hcv ns5b polymerase
|
US6973905B2
(en)
|
2002-07-01 |
2005-12-13 |
Cinetic Automation Corporation |
Valve lash adjustment apparatus and method
|
EP1532128A1
(en)
|
2002-07-01 |
2005-05-25 |
Pharmacia & Upjohn Company LLC |
Inhibitors of hcv ns5b polymerase
|
CA2490666A1
(en)
|
2002-07-16 |
2004-01-22 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
EP1572709A3
(en)
|
2002-07-24 |
2005-11-23 |
PTC Therapeutics, Inc. |
Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases
|
AU2003256619A1
(en)
|
2002-07-24 |
2004-02-09 |
Isis Pharmaceuticals, Inc. |
Pyrrolopyrimidine thionucleoside analogs as antivirals
|
WO2004011478A2
(en)
|
2002-07-25 |
2004-02-05 |
Micrologix Biotech Inc. |
Anti-viral 7-deaza d-nucleosides and uses thereof
|
TWI244393B
(en)
|
2002-08-06 |
2005-12-01 |
Idenix Pharmaceuticals Inc |
Crystalline and amorphous forms of beta-L-2'-deoxythymidine
|
AU2003264038A1
(en)
|
2002-08-12 |
2004-02-25 |
Bristol-Myers Squibb Company |
Combination pharmaceutical agents as inhibitors of hcv replication
|
SI1572095T1
(sl)
|
2002-09-13 |
2015-12-31 |
Novartis Ag |
Beta-l-2'-deoksinukleozidi za uporabo pri zdravljenju odpornih sevov hbv
|
JP2006505571A
(ja)
|
2002-10-15 |
2006-02-16 |
リゲル ファーマシューテイカルズ、インコーポレイテッド |
置換されたインドール及びhcv阻害剤としてのその使用
|
US20040229840A1
(en)
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
UA79834C2
(en)
|
2002-11-01 |
2007-07-25 |
Viropharma Inc |
Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
|
AU2003290596B2
(en)
|
2002-11-05 |
2011-05-12 |
Isis Pharmaceuticals, Inc. |
Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
AU2003291753B2
(en)
|
2002-11-05 |
2010-07-08 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
CA2506129C
(en)
|
2002-11-15 |
2015-02-17 |
Idenix (Cayman) Limited |
2'-branched nucleosides and flaviviridae mutation
|
TWI332507B
(en)
|
2002-11-19 |
2010-11-01 |
Hoffmann La Roche |
Antiviral nucleoside derivatives
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
EP1629000B1
(en)
|
2003-04-16 |
2009-02-18 |
Bristol-Myers Squibb Company |
Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus
|
US20050261237A1
(en)
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
EP1617848A2
(en)
|
2003-04-25 |
2006-01-25 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate conjugates
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
US7429565B2
(en)
|
2003-04-25 |
2008-09-30 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020884A2
(en)
|
2003-05-14 |
2005-03-10 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
SI2604620T1
(sl)
|
2003-05-30 |
2016-10-28 |
Gilead Pharmasset LLC c/o Gilead Sciences, Inc. |
Modificirani fluorirani nukleozidni analogi
|
GB0317009D0
(en)
|
2003-07-21 |
2003-08-27 |
Univ Cardiff |
Chemical compounds
|
ES2351603T3
(es)
|
2003-07-25 |
2011-02-08 |
Idenix Pharmaceuticals, Inc. |
Análogos de nucleósidos de purina para el tratamiento de enfermedades causadas por flaviridae incluyendo hepatitis c.
|
CN1863813B
(zh)
|
2003-08-27 |
2011-03-30 |
生物区科学管理控股有限公司 |
作为治疗剂的三环核苷或核苷酸
|
EP1677822B1
(en)
|
2003-09-18 |
2014-04-23 |
Isis Pharmaceuticals, Inc. |
4'-thionucleosides and oligomeric compounds
|
WO2005028502A1
(en)
|
2003-09-18 |
2005-03-31 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
US20050148534A1
(en)
|
2003-09-22 |
2005-07-07 |
Castellino Angelo J. |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
WO2005036994A1
(en)
|
2003-10-14 |
2005-04-28 |
Lyco Manufacturing, Inc. |
High speed food product peeling or cleaning machine and method
|
DE602004018363D1
(de)
|
2003-10-27 |
2009-01-22 |
Vertex Pharma |
Kombinationen für die hcv-behandlung
|
US7026339B2
(en)
|
2003-11-07 |
2006-04-11 |
Fan Yang |
Inhibitors of HCV NS5B polymerase
|
TW200528459A
(en)
|
2004-01-06 |
2005-09-01 |
Achillion Pharmaceuticals Inc |
Azabenzofuran substituted thioureas; inhibitors of viral replication
|
WO2005082144A1
(en)
|
2004-02-25 |
2005-09-09 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer |
Methylation inhibitor compounds
|
EP1745154B1
(en)
|
2004-05-07 |
2012-08-01 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
|
CA2568735A1
(en)
|
2004-06-03 |
2005-12-22 |
Isis Pharmaceuticals, Inc. |
Double strand compositions comprising differentially modified strands for use in gene modulation
|
US8394947B2
(en)
|
2004-06-03 |
2013-03-12 |
Isis Pharmaceuticals, Inc. |
Positionally modified siRNA constructs
|
WO2005121634A1
(ja)
|
2004-06-08 |
2005-12-22 |
Tokyo Gas Co., Ltd. |
ガス吸着容器
|
EP1758453B1
(en)
|
2004-06-15 |
2014-07-16 |
Merck Sharp & Dohme Corp. |
C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase
|
CA2571675A1
(en)
|
2004-06-23 |
2006-01-05 |
Idenix (Cayman) Limited |
5-aza-7-deazapurine derivatives for treating infections with flaviviridae
|
US20070265222A1
(en)
|
2004-06-24 |
2007-11-15 |
Maccoss Malcolm |
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
NZ552927A
(en)
|
2004-07-21 |
2010-05-28 |
Pharmasset Inc |
Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives
|
JP2008508291A
(ja)
|
2004-07-27 |
2008-03-21 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗hiv剤としてのヌクレオシドホスホネート結合体
|
US7153848B2
(en)
|
2004-08-09 |
2006-12-26 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
US7348425B2
(en)
|
2004-08-09 |
2008-03-25 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
DE602005015466D1
(de)
|
2004-08-23 |
2009-08-27 |
Hoffmann La Roche |
Antivirale 4'-azidonucleoside
|
EP1786807B1
(en)
|
2004-08-23 |
2009-07-29 |
F.Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
WO2006029081A2
(en)
|
2004-09-02 |
2006-03-16 |
Neopharm, Inc. |
Nucleoside-lipid conjugates, their method of preparation and uses thereof
|
EP3109244B1
(en)
|
2004-09-14 |
2019-03-06 |
Gilead Pharmasset LLC |
Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
BRPI0515896A
(pt)
|
2004-09-24 |
2008-08-12 |
Idenix Cayman Ltd E Ct Nat De |
composto ou um sal ou éster farmaceuticamente aceitável do mesmo, método para o tratamento ou profilaxia de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus, e, composição farmacêutica para o tratamento de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus
|
JP5046942B2
(ja)
|
2004-09-30 |
2012-10-10 |
テイボテク・フアーマシユーチカルズ |
Hcv阻害性の二環式ピリミジン類
|
WO2006065335A2
(en)
|
2004-10-21 |
2006-06-22 |
Merck & Co., Inc. |
Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection
|
US8133870B2
(en)
|
2004-10-29 |
2012-03-13 |
Biocryst Pharmaceuticals, Inc. |
Therapeutic furopyrimidines and thienopyrimidines
|
US20060110724A1
(en)
|
2004-11-19 |
2006-05-25 |
Burkhardt William Iii |
Quantitative real-time assay for noroviruses and enteroviruses with built in quality control standard
|
EP1674104A1
(en)
|
2004-12-24 |
2006-06-28 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Uridine derivatives as antiviral drugs against a flaviviridae, especially HCV
|
WO2006093801A1
(en)
|
2005-02-25 |
2006-09-08 |
Abbott Laboratories |
Thiadiazine derivatives useful as anti-infective agents
|
EA200701849A1
(ru)
|
2005-02-28 |
2008-02-28 |
Дженелабс Текнолоджис, Инк. |
Пролекарственные соединения трициклических нуклеозидов, фармацевтическая композиция на их основе и способ лечения и/или ингибирования вирусной инфекции у млекопитающего
|
AU2006226322B2
(en)
|
2005-03-25 |
2012-03-29 |
Tibotec Pharmaceuticals Ltd. |
Heterobicylic inhibitors of HCV
|
TW200720285A
(en)
|
2005-04-25 |
2007-06-01 |
Genelabs Tech Inc |
Nucleoside compounds for treating viral infections
|
WO2006121820A1
(en)
|
2005-05-05 |
2006-11-16 |
Valeant Research & Development |
Phosphoramidate prodrugs for treatment of viral infection
|
AR056347A1
(es)
|
2005-05-12 |
2007-10-03 |
Tibotec Pharm Ltd |
Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas
|
US20060276405A1
(en)
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Methods for treating hepatitis C
|
US8143288B2
(en)
|
2005-06-06 |
2012-03-27 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
US20060293752A1
(en)
|
2005-06-27 |
2006-12-28 |
Missoum Moumene |
Intervertebral disc prosthesis and associated methods
|
MX2008001166A
(es)
|
2005-07-25 |
2008-03-18 |
Intermune Inc |
Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
|
CN101282978B
(zh)
|
2005-07-29 |
2012-07-11 |
泰博特克药品有限公司 |
丙型肝炎病毒的大环抑制剂
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
AU2006274861B2
(en)
|
2005-07-29 |
2012-11-08 |
Medivir Ab |
Macrocyclic inhibitors of hepatitis C virus
|
RU2437886C2
(ru)
|
2005-07-29 |
2011-12-27 |
Тиботек Фармасьютикалз Лтд. |
Макроциклические ингибиторы вируса гепатита с
|
BRPI0614621A2
(pt)
|
2005-07-29 |
2011-04-12 |
Tibotec Pharm Ltd |
inibidores macrocìclicos de vìrus da hepatite c
|
EP1928475B1
(en)
|
2005-08-15 |
2018-05-23 |
Riboscience LLC |
Antiviral phosphoramidates of 4'-c-azido-substituted pronucleotides
|
AU2006294807B2
(en)
|
2005-09-26 |
2013-01-17 |
Gilead Pharmasset Llc |
Modified 4'-nucleosides as antiviral agents
|
JP5116687B2
(ja)
|
2005-11-02 |
2013-01-09 |
バイエル・ファルマ・アクチェンゲゼルシャフト |
がんおよび他の過剰増殖性疾患の処置のためのピロロ[2,1−f][1,2,4]トリアジン−4−イルアミンIGF−1Rキナーゼ阻害剤
|
EP1957510A1
(en)
|
2005-12-09 |
2008-08-20 |
F.Hoffmann-La Roche Ag |
Antiviral nucleosides
|
WO2007070556A2
(en)
|
2005-12-12 |
2007-06-21 |
Genelabs Technologies, Inc. |
N-(6-membered aromatic ring)-amido anti-viral compounds
|
WO2007076034A2
(en)
|
2005-12-21 |
2007-07-05 |
Abbott Laboratories |
Anti-viral compounds
|
DE602006015861D1
(de)
|
2005-12-21 |
2010-09-09 |
Abbott Lab |
Antivirale verbindungen
|
CA2637879A1
(en)
|
2006-02-14 |
2007-08-23 |
Merck & Co., Inc. |
Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
|
ATE532784T1
(de)
|
2006-02-17 |
2011-11-15 |
Pfizer Ltd |
3-deazapurinderivate als tlr7-modulatoren
|
US8895531B2
(en)
|
2006-03-23 |
2014-11-25 |
Rfs Pharma Llc |
2′-fluoronucleoside phosphonates as antiviral agents
|
DE602007006796D1
(de)
|
2006-05-25 |
2010-07-08 |
Bristol Myers Squibb Co |
Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b-hemmer
|
WO2007140200A2
(en)
|
2006-05-25 |
2007-12-06 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
|
AP3430A
(en)
|
2006-07-07 |
2015-09-30 |
Gileas Sciences Inc |
Novel pyridazine compound and use thereof
|
TW200819460A
(en)
|
2006-07-07 |
2008-05-01 |
Gilead Sciences Inc |
Antiviral phosphinate compounds
|
US7939553B2
(en)
|
2006-07-07 |
2011-05-10 |
Gilead Sciences, Inc. |
Modulators of pharmacokinetic properties of therapeutics
|
DK2038290T3
(da)
|
2006-07-07 |
2013-12-02 |
Gilead Sciences Inc |
Modulatorer af toll-lignende receptor 7
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8303944B2
(en)
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2666098C
(en)
|
2006-10-10 |
2012-09-25 |
Steven D. Axt |
Preparation of nucleosides ribofuranosyl pyrimidines
|
PL216525B1
(pl)
|
2006-10-17 |
2014-04-30 |
Ct Badań Molekularnych I Makromolekularnych Polskiej Akademii Nauk |
5'-O-[(N-acylo)amidoditiofosforano] nukleozydy oraz sposób wytwarzania 5'-O-[(N-acylo)amidofosforano]-,5'-O-[(N-acylo)amidotiofosforano]-, 5'-O-[(N-acylo)amidoditiofosforano]nukleozydów
|
CA2672613A1
(en)
|
2006-12-20 |
2008-07-03 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection
|
US7951789B2
(en)
|
2006-12-28 |
2011-05-31 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
US8071568B2
(en)
|
2007-01-05 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
CA2686051A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Combination therapy for the treatment of hcv infection
|
US7741347B2
(en)
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
GB0709791D0
(en)
|
2007-05-22 |
2007-06-27 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
JPWO2008156094A1
(ja)
|
2007-06-19 |
2010-08-26 |
杏林製薬株式会社 |
ピリダジノン誘導体及びそれらを有効成分とするpde阻害剤
|
UA98494C2
(xx)
|
2007-06-29 |
2012-05-25 |
Гіліад Сайєнсіз, Інк. |
Противірусні сполуки$противовирусные соединения
|
BRPI0813733A2
(pt)
|
2007-06-29 |
2019-11-05 |
Gilead Sciences Inc |
composto com atividade inibidora de hcv, sua composição farmacêutica e seu uso.
|
NZ582090A
(en)
|
2007-06-29 |
2012-05-25 |
Gilead Sciences Inc |
Purine derivatives and their use as modulators of toll-like receptor 7
|
UA99466C2
(xx)
|
2007-07-06 |
2012-08-27 |
Гилиад Сайенсиз, Инк. |
Кристалічна сполука піридазину$кристаллическое соединение пиридазина
|
CN101108870A
(zh)
|
2007-08-03 |
2008-01-23 |
冷一欣 |
核苷磷酸酯类化合物及制备方法和应用
|
US8629171B2
(en)
|
2007-08-08 |
2014-01-14 |
Bristol-Myers Squibb Company |
Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
|
US7728027B2
(en)
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
AU2008301981A1
(en)
|
2007-09-14 |
2009-03-26 |
Merck Sharp & Dohme Corp. |
Method of treating hepatitis C patients
|
JO2778B1
(en)
|
2007-10-16 |
2014-03-15 |
ايساي انك |
Certain vehicles, installations and methods
|
DE102007052070A1
(de)
|
2007-10-30 |
2009-05-07 |
Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg |
Candesartancilexetil
|
JP5238939B2
(ja)
|
2007-11-07 |
2013-07-17 |
三菱化学株式会社 |
長繊維強化複合樹脂組成物および成形品
|
KR20100120656A
(ko)
|
2008-01-11 |
2010-11-16 |
안타리아 리미티드 |
시각적으로 투명한 uv 광보호성 조성물
|
MX2010008650A
(es)
|
2008-02-12 |
2010-08-30 |
Bristol Myers Squibb Co |
Inhibidores de virus de la hepatitis c.
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
BRPI0822323A2
(pt)
|
2008-02-13 |
2015-06-16 |
Bristol Myers Squibb Co |
Imidazolil bifenil imidazóis como inibidores do vírus da hepatite c
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8227431B2
(en)
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
WO2009120878A2
(en)
|
2008-03-26 |
2009-10-01 |
Alnylam Pharmaceuticals, Inc. |
Non-natural ribonucleotides, and methods of use thereof
|
US8415321B2
(en)
|
2008-04-15 |
2013-04-09 |
Raymond F. Schinazi |
Nucleoside derivatives for treatment of Caliciviridae infections, including Norovirus infections
|
JP2011519364A
(ja)
|
2008-04-15 |
2011-07-07 |
インターミューン・インコーポレーテッド |
C型肝炎ウイルス複製の新規大環状阻害剤
|
KR101681559B1
(ko)
|
2008-04-23 |
2016-12-01 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 치료를 위한 1'-치환된 카바-뉴클레오사이드 유사체
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
MX2011000060A
(es)
|
2008-07-10 |
2011-02-22 |
Prosidion Ltd |
Agonistas del receptor acoplado a la proteina g piperidinilo.
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7921612B2
(en)
|
2008-08-31 |
2011-04-12 |
United Construction Products, Inc. |
Method and device for supporting a structure
|
US8383094B2
(en)
|
2008-10-01 |
2013-02-26 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
DE102008057284A1
(de)
|
2008-11-14 |
2010-05-20 |
Ratiopharm Gmbh |
Tabletten enthaltend Lenalidomid und Adhäsionsverstärker
|
WO2010062821A1
(en)
|
2008-11-28 |
2010-06-03 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
WO2010065674A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
US8865756B2
(en)
|
2008-12-03 |
2014-10-21 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
KR101687841B1
(ko)
|
2008-12-09 |
2016-12-19 |
길리애드 사이언시즈, 인코포레이티드 |
톨-유사 수용체의 조절제
|
EP2376088B1
(en)
|
2008-12-23 |
2017-02-22 |
Gilead Pharmasset LLC |
6-O-Substituted-2-amino-purine nucleoside phosphoramidates
|
AU2009329917B2
(en)
|
2008-12-23 |
2016-03-31 |
Gilead Pharmasset Llc |
Nucleoside analogs
|
KR20110104074A
(ko)
|
2008-12-23 |
2011-09-21 |
파마셋 인코포레이티드 |
퓨린 뉴클레오시드의 합성
|
BRPI1007027A2
(pt)
|
2009-01-07 |
2019-09-24 |
Scynexis Inc |
combinação de um derivado de ciclosporina e nucleosídeos para tratar do hcv
|
JP2012514657A
(ja)
|
2009-01-09 |
2012-06-28 |
ユニバーシテイ・カレツジ・オブ・カーデイフ・コンサルタンツ・リミテツド |
ウィルス感染を治療するためのグアノシンヌクレオシド化合物のホスホルアミダート誘導体
|
WO2010091413A1
(en)
|
2009-02-09 |
2010-08-12 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
WO2010094977A1
(en)
|
2009-02-23 |
2010-08-26 |
Arrow Therapeutics Limited |
Novel biphenyl compounds useful for the treatment of hepatitis c
|
US20120040977A1
(en)
|
2009-02-23 |
2012-02-16 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
NZ595280A
(en)
|
2009-02-27 |
2013-11-29 |
Enanta Pharm Inc |
Hepatitis c virus inhibitors
|
EA201190178A1
(ru)
|
2009-03-20 |
2012-06-29 |
Алиос Биофарма, Инк. |
Замещённые нуклеозидные и нуклеотидные аналоги
|
BRPI1013394B1
(pt)
|
2009-03-27 |
2022-04-19 |
Merck Sharp & Dohme Corp |
Composto inibidor da replicação do vírus da hepatite c, sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, usos do composto e do sal farmaceuticamente aceitável do mesmo
|
MX2011010132A
(es)
|
2009-03-27 |
2011-10-14 |
Presidio Pharmaceuticals Inc |
Inhibidores de anillo fusionado de hepatitis c.
|
EP2410841A4
(en)
|
2009-03-27 |
2012-10-24 |
Presidio Pharmaceuticals Inc |
SUBSTITUTED BICYCLIC HCV INHIBITORS
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
TWI476190B
(zh)
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
DE102009015702A1
(de)
|
2009-03-31 |
2010-10-07 |
Ratiopharm Gmbh |
Tabletten enthaltend Dapoxetin und Trockenverarbeitungsverfahren zu deren Herstellung
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2010120935A1
(en)
|
2009-04-15 |
2010-10-21 |
Abbott Laboratories |
Anti-viral compounds
|
BRPI1016172A2
(pt)
|
2009-04-24 |
2016-04-19 |
Tibotec Pharm Ltd |
éteres diarílicos
|
WO2010132538A1
(en)
|
2009-05-12 |
2010-11-18 |
Schering Corporation |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
RS54386B8
(sr)
|
2009-05-13 |
2021-06-30 |
Gilead Pharmasset Llc |
Antiviralna jedinjenja
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CA2762885A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
|
WO2010138791A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
SI2628481T1
(sl)
|
2009-06-11 |
2016-08-31 |
Abb Vie Bahamas Limited |
Trisubstituirani heterocikli kot inhibitorji replikacije HCV virusa hepatitisa C
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
WO2010148006A1
(en)
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
WO2011004276A1
(en)
|
2009-07-06 |
2011-01-13 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
JP5542910B2
(ja)
|
2009-07-13 |
2014-07-09 |
株式会社メニコン |
広範囲の抗菌活性を有するコーティング剤としてのキトサンヒドロゲル誘導体
|
WO2011009084A2
(en)
|
2009-07-16 |
2011-01-20 |
Vertex Pharmaceuticals Incorporated |
Benzimidazole analogues for the treatment or prevention of flavivirus infections
|
WO2011009961A1
(en)
|
2009-07-24 |
2011-01-27 |
Virologik Gmbh |
Combination of proteasome inhibitors and anti-hepatitis medication for treating hepatitis
|
AU2010280712B2
(en)
|
2009-08-07 |
2015-10-22 |
Janssen Sciences Ireland Uc |
Bis-benzimidazole derivatives as hepatitis C virus inhibitors
|
WO2011015657A1
(en)
|
2009-08-07 |
2011-02-10 |
Tibotec Pharmaceuticals |
Phenyl ethynyl derivatives as hepatitis c virus inhibitors
|
FR2949465B1
(fr)
|
2009-09-01 |
2011-08-12 |
Pf Medicament |
Derives chromones, leur procede de preparation et leurs applications therapeutiques
|
EP2473503B1
(en)
|
2009-09-03 |
2014-07-23 |
Janssen R&D Ireland |
Bis-benzimidazole derivatives
|
EP2473056A4
(en)
|
2009-09-04 |
2013-02-13 |
Glaxosmithkline Llc |
CHEMICAL COMPOUNDS
|
WO2011031904A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
EP2475254A4
(en)
|
2009-09-11 |
2013-05-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
ES2730805T3
(es)
|
2009-09-21 |
2019-11-12 |
Gilead Sciences Inc |
Análogos de carba-nucleósido sustituido por 2'-fluoro para el tratamiento antiviral
|
US8415374B2
(en)
|
2009-10-12 |
2013-04-09 |
Bristol-Myers Squibb Company |
Combinations of hepatitis C virus inhibitors
|
WO2011050146A1
(en)
|
2009-10-23 |
2011-04-28 |
Glaxosmithkline Llc |
Chemical compounds
|
UA108211C2
(xx)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
CN102055717B
(zh)
|
2009-11-09 |
2014-08-13 |
华为技术有限公司 |
快速播放的方法、终端及服务器
|
US20110274648A1
(en)
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110269956A1
(en)
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20110281910A1
(en)
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
US20120276047A1
(en)
|
2009-11-25 |
2012-11-01 |
Rosenblum Stuart B |
Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
|
US20110137633A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Anti-viral compounds and methods of identifying the same
|
US8653070B2
(en)
|
2009-12-14 |
2014-02-18 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
US8377980B2
(en)
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
CN104341401B
(zh)
|
2009-12-18 |
2017-02-15 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
MX2012007076A
(es)
*
|
2009-12-18 |
2012-07-20 |
Boehringer Ingelheim Int |
Terapia combinada de hcv.
|
MX2012006877A
(es)
|
2009-12-18 |
2012-08-31 |
Idenix Pharmaceuticals Inc |
Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado.
|
CA2785488A1
(en)
|
2009-12-22 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
MX2012007420A
(es)
|
2009-12-24 |
2012-07-23 |
Vertex Pharma |
Analogos para el tratamiento o prevencion de infecciones de flavivirus.
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
AR080001A1
(es)
*
|
2010-01-15 |
2012-03-07 |
Gilead Sciences Inc |
Inhibidores de virus flaviviridae
|
WO2011091446A1
(en)
|
2010-01-22 |
2011-07-28 |
Glaxosmithkline Llc |
Chemical compounds
|
KR20130008040A
(ko)
|
2010-03-09 |
2013-01-21 |
머크 샤프 앤드 돔 코포레이션 |
융합된 트리시클릭 실릴 화합물 및 바이러스성 질환의 치료를 위한 그의 사용 방법
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
HUE034239T2
(en)
|
2010-03-31 |
2018-02-28 |
Gilead Pharmasset Llc |
Method for Crystallization of (S) -isopropyl 2 - (((S) (perfluorophenoxy) (phenoxy) phosphoryl) amino) propanoate \ t
|
WO2011123672A1
(en)
|
2010-03-31 |
2011-10-06 |
Pharmasset, Inc. |
Purine nucleoside phosphoramidate
|
JP2013529068A
(ja)
|
2010-04-13 |
2013-07-18 |
エフ.ホフマン−ラ ロシュ アーゲー |
Hcv治療における早期ウイルス応答の予測
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
AR084393A1
(es)
|
2010-06-10 |
2013-05-15 |
Gilead Sciences Inc |
Metodos para tratar el virus de la hepatitis c, composicion, uso, combinacion, kit y uno o mas compuestos anti vhc
|
EP2596004B1
(en)
|
2010-07-19 |
2014-09-10 |
Gilead Sciences, Inc. |
Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
|
WO2012027712A2
(en)
|
2010-08-26 |
2012-03-01 |
Rfs Pharma, Llc |
Potent and selective inhibitors of hepatitis c virus
|
JP2013538230A
(ja)
|
2010-09-20 |
2013-10-10 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス治療用の2’−フルオロ置換カルバヌクレオシド類似体
|
WO2012041014A1
(en)
|
2010-09-29 |
2012-04-05 |
Merck Sharp & Dohme Corp. |
Tetracyclic indole derivatives for treating hepatitis c virus infection
|
WO2012048421A1
(en)
|
2010-10-14 |
2012-04-19 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor compounds
|
US20120107278A1
(en)
|
2010-10-29 |
2012-05-03 |
Pharmasset, Inc. |
Abbreviated hcv therapy for hcv infected patients with il28b c/c genotype
|
NZ726475A
(en)
|
2010-11-17 |
2018-07-27 |
Gilead Pharmasset Llc |
Antiviral compounds
|
TW201242974A
(en)
|
2010-11-30 |
2012-11-01 |
Gilead Pharmasset Llc |
Compounds
|
TW201701876A
(zh)
|
2010-12-20 |
2017-01-16 |
吉李德科學股份有限公司 |
治療c型肝炎病毒(hcv)之方法
|
WO2012087976A2
(en)
|
2010-12-21 |
2012-06-28 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
KR20140002018A
(ko)
|
2011-03-31 |
2014-01-07 |
에프. 호프만-라 로슈 아게 |
Hcv 치료의 선택
|
US8655250B2
(en)
|
2011-03-31 |
2014-02-18 |
Xerox Corporation |
Apparatus and method for marking material fix level control in a printing apparatus
|
KR20140064765A
(ko)
|
2011-06-30 |
2014-05-28 |
스텔라 에이피에스 |
Hcv 조합 치료
|
SG11201400664WA
(en)
|
2011-09-16 |
2014-04-28 |
Gilead Pharmassett Llc |
Methods for treating hcv
|
DE202012013117U1
(de)
|
2011-10-21 |
2015-01-16 |
Abbvie Inc. |
Kombinationsbehandlung (z.B. mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV)
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
DE112012003510T5
(de)
|
2011-10-21 |
2015-03-19 |
Abbvie Inc. |
Verfahren zur Behandlung von HCV umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin aber nicht Interferon
|
JP2014532657A
(ja)
|
2011-10-31 |
2014-12-08 |
ギリアド ファーマセット エルエルシー |
C型肝炎ウイルスを処置するための方法および組成物
|
US20130109647A1
(en)
|
2011-10-31 |
2013-05-02 |
Gilead Pharmasset Llc |
Methods and compositions for treating hepatitis c virus
|
CN103328480B
(zh)
|
2011-11-16 |
2016-05-25 |
吉利德法莫赛特有限责任公司 |
作为抗病毒化合物的缩合的咪唑基咪唑
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
CA2856529C
(en)
|
2011-11-29 |
2018-03-06 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis c virus
|
MX2014008008A
(es)
|
2011-12-29 |
2014-08-21 |
Abbvie Inc |
Composiciones solidas que comprenden un inhibidor del virus de la hepatitis c.
|
CA2863282A1
(en)
|
2012-01-13 |
2013-07-18 |
Gilead Pharmasset Llc |
Crystal structure of hcv polymerase complexes and methods of use
|
US8969588B2
(en)
|
2012-06-05 |
2015-03-03 |
Gilead Pharmasset Llc |
Solid forms of an antiviral compound
|
US9056860B2
(en)
|
2012-06-05 |
2015-06-16 |
Gilead Pharmasset Llc |
Synthesis of antiviral compound
|
TW201446286A
(zh)
|
2013-01-31 |
2014-12-16 |
Gilead Pharmasset Llc |
抗病毒化合物之固態分散調製劑
|
PT2950786T
(pt)
|
2013-01-31 |
2020-03-03 |
Gilead Pharmasset Llc |
Formulação de combinação de dois compostos antivirais
|
US20140249101A1
(en)
|
2013-03-04 |
2014-09-04 |
Gilead Pharmasset Llc |
Methods for treating hepatitis c virus infection
|
US20140343008A1
(en)
|
2013-05-16 |
2014-11-20 |
Gilead Pharmasset Llc |
Hepatitis c treatment
|